DEA and ATF use of “informants” subject of Congressional hearings starting today.
Congress will hear testimony from Inspector General on use of informants by ATF and DEA. The transcripts of the hearings and the reports should be obtained by any federal criminal defense practitioner.
The link on the House Oversight Committee is found here.
USE OF CONFIDENTIAL INFORMANTS AT ATF AND DEA
Full House Committee on Oversight and Government Reform
FULL HOUSE COMMITTEE ON OVERSIGHT AND GOVERNMENT REFORM
HEARING DATE: APRIL 4, 2017 10:00 AM 2154 RAYBURN HOB
To examine the Bureau of Alcohol, Tobacco, Firearms and Explosives’ (ATF) oversight and management of its confidential informants (CIs), changes it has made to the program, and ATF’s progress in implementing the Department of Justice Office of Inspector General’s (DOJ OIG) recommendations.
To follow up on the Drug Enforcement Agency’s (DEA) progress in implementing DOJ OIG’s recommendations.
DOJ OIG recently found that while ATF’s CI policies generally align with DOJ guidelines, ATF’s oversight of the program requires significant improvement.
ATF could not easily identify and track total payments made to individual informants, and it did not have reliable information about some higher-risk CIs.
In November 2016, the committee held a hearing about DOJ OIG’s audit of DEA’s use of CIs, which found that DEA failed to sufficiently review, authorize, and implement controls for CIs’ activities and payments. The committee continues to await DEA’s production of its revised policy on the use of CIs.
The Honorable Michael E. Horowitz
Department of Justice
Mr. Robert Patterson
Acting Principal Deputy Administrator
Drug Enforcement Administration
Mr. Ronald B. Turk
Associate Deputy Director and Chief Operating Officer
Bureau of Alcohol, Tobacco, Firearms and Explosives